C12N 2750/10022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2750/10022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 139 US grants and 177 published applications in this corpus.
Search patents in C12N- Granted patents
- 139
- Published applications
- 177
- Assignees
- 70
- Inventors
- 240
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 0 |
| 2002 | 3 | 6 |
| 2003 | 5 | 5 |
| 2004 | 1 | 10 |
| 2005 | 3 | 7 |
| 2006 | 3 | 7 |
| 2007 | 12 | 11 |
| 2008 | 8 | 11 |
| 2009 | 3 | 10 |
| 2010 | 15 | 19 |
| 2011 | 6 | 10 |
| 2012 | 1 | 3 |
| 2013 | 1 | 6 |
| 2014 | 3 | 8 |
| 2015 | 4 | 10 |
| 2016 | 6 | 8 |
| 2017 | 11 | 7 |
| 2018 | 13 | 7 |
| 2019 | 4 | 2 |
| 2020 | 6 | 7 |
| 2021 | 4 | 5 |
| 2022 | 2 | 6 |
| 2023 | 3 | 1 |
| 2024 | 3 | 3 |
| 2025 | 4 | 5 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Porcine circovirus type 2 VLP vaccine6 Jan 2026US 12,514,916 B2Meiji Animal Health Co., Ltd.
- Porcine circovirus type 3 (PCV3) vaccines, and production and uses thereof7 Oct 2025US 12,433,942 B2
- Chimeric protein toxins for expression by therapeutic bacteria5 Aug 2025US 12,378,536 B1
- Porcine circovirus type 3 immunogenic compositions and methods of making and using the same17 Jun 2025US 12,331,080 B2Kansas State University Research Foundation
- PCV2 ORF2 protein variant and virus like particles composed thereof11 Mar 2025US 12,247,051 B2
- Compositions and methods including rna-binding proteins24 Sep 2026US 2026/0286325 A1Regents of the University of Minnesota
- Identification of a human circovirus4 Jun 2026US 2026/0152812 A1
- Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof12 Mar 2026US 2026/0069672 A1Boehringer Ingelheim Vetmedica GmbH
- Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use30 Oct 2025US 2025/0332242 A1Zoetis Services LLC
- Oral vaccine composition23 Oct 2025US 2025/0325647 A1Kaico Ltd.
Most cited
By later US patents
- Porcine circovirus and paravovirus vaccine105US 6,217,883 B1Merial Limited · 2001
- Porcine circoviruses vaccines diagnostic reagents105US 6,391,314 B1Merial Limited · 2002
- Porcine circovirus vaccine and diagnostics reagents99US 6,368,601 B1Merial Limited · 2002
- Porcine circovirus recombinant poxvirus vaccine87US 6,497,883 B1Merial Limited · 2002
- Vaccines against circovirus infections85US 6,287,856 B1University of Georgia Research Foundation, Inc. · 2001